Press releases
- Orthofix Names Max Reinhardt President of Global Spine Business
- Orthofix Wins “Best Patient Experience Solution” Award in 2024 MedTech Breakthrough Awards Program
- Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
- Orthofix Reports First Quarter 2024 Results
- Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
- Orthofix Names Andres Cedron as New Chief Legal Officer
- Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
- Orthofix Reports Fourth Quarter and Full Year 2023 Results
- Orthofix Announces New President for Bone Growth Therapies Business
More ▼
Key statistics
As of last trade, Orthofix Medical Inc (OM2:FRA) traded at 13.20, 48.31% above the 52 week low of 8.90 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.20 |
---|---|
High | 13.20 |
Low | 13.20 |
Bid | 13.30 |
Offer | 13.70 |
Previous close | 13.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | 37.53m |
Free float | 35.89m |
P/E (TTM) | -- |
Market cap | 546.80m USD |
EPS (TTM) | -3.40 USD |
Data delayed at least 15 minutes, as of May 23 2024 07:08 BST.
More ▼